Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction

Authors

EPI Study Group
Chadi A Hage, Indiana University
Suresh Vedantham, Washington University School of Medicine in St. Louis
Mary Clare Derfler, Washington University School of Medicine in St. Louis
Paul Commean, Washington University School of Medicine in St. Louis
Ed Spitznagel, Washington University in St. Louis
Jeff Atkinson, Washington University School of Medicine in St. Louis
George Despotis, Washington University School of Medicine in St. Louis
et al.

Journal

Transfusion medicine

Publication Date

8-1-2021

Volume

31

Issue

4

First Page

292

Last Page

302

Document Type

Open Access Publication

DOI

10.1111/tme.12779

Rights and Permissions

The EPI Study Group, Hage CA, Klesney-Tait J, Wille K, et al. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction. Transfusion Medicine. 2021; 31: 292–302. https://doi.org/10.1111/tme.12779 © 2021 The Authors. Transfusion Medicine published by John Wiley & Sons Ltd on behalf of British Blood Transfusion Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Recommended Citation

EPI Study Group; Hage, Chadi A; Vedantham, Suresh; Derfler, Mary Clare; Commean, Paul; Spitznagel, Ed; Atkinson, Jeff; Despotis, George; and et al., "Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction." Transfusion medicine. 31, 4. 292 - 302. (2021).
https://digitalcommons.wustl.edu/oa_4/3018

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.